Blog

Emre Yekedüz: Molecular biomarkers of progression in non-muscle-invasive bladder cancer

Photo taken from Erasmus MC

Aug 7, 2024, 05:31

Emre Yekedüz: Molecular biomarkers of progression in non-muscle-invasive bladder cancer

Emre Yekedüz, Associate Professor of Medical Oncology at Ankara University and Research Fellow at shared a post on X about a recent paper by Mitchell Olislagers et al., commenting:

“A must-read review on Molecular biomarkers of progression in non-muscle-invasive bladder cancer beyond conventional risk stratification.”

Molecular biomarkers of progression in non-muscle-invasive bladder cancer — beyond conventional risk stratification published in Nature Reviews Urology.

Authors: Mitchell Olislagers, Florus C. de Jong, Vera C. Rutten, Joost L. Boormans, Tokameh Mahmoudi and Tahlita C. M. Zuiverloon.

Emre Yekedüz

Additional information
Source: Emre Yekedüz/X

cancer Emre Yekedüz Florus C. de Jong Joost L. Boormans Mitchell Olislagers OncoDaily Oncology Tahlita C. M. Zuiverloon Tokameh Mahmoudi Vera C. Rutten

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer